amo-pharma.com Report : Visit Site

Technical data of the amo-pharma.com

Geo IP provides you such as latitude, longitude and ISP (Internet Service Provider) etc. informations. Our GeoIP service found where is host amo-pharma.com. Currently, hosted in United Kingdom and its service provider is NetDirect .

the related websites

link.springer.com acaciapharma.com vernalis.com dvds2trade.co.uk cooperhay.com ponderosa-park.co.uk dailymail.co.uk zimeye.net keymailorder.com hpcnursing.com embassystamps.co.uk 

HTTP Header Analysis

HTTP Header information is a part of HTTP protocol that a user's browser sends to called Apache containing the details of what the browser wants and will accept back from the web server.

DNS

HtmlToText

amo pharma - building a portfolio of high impact new medicines home about leadership investors amo pharma at a glance pipeline amo-01 amo-02 amo-04 rnd-001 patients phelan-mcdermid syndrome congenital myotonic dystrophy rett syndrome lysosomal storage disorders partnerships news contact us -- proud sponsor of the phelan-mcdermid syndrome foundation 2018 international family conference and phelan-mcposium read more amo newsletter july 2018 download pdf building a portfolio of high impact new medicines amo pharma is dedicated to making a positive difference for people affected by serious and debilitating diseases, particularly rare or orphan diseases. read more a better business model in its business strategy and clinical development programs, amo pharma maintains a constant focus on delivering value to patients. read more leadership amo pharma is led by a team of industry professionals who combine extensive experience in biomedical science and research. read more amo pharma is a privately held emerging biopharmaceutical company developing new treatments for serious and debilitating diseases including rare genetic disorders. our goal is to identify and advance a robust pipeline of promising therapies for patient populations with significant areas of unmet need. the company is led by seasoned industry professionals with extensive experience in all phases of asset acquisition and drug development and commercialization. the amo pharma portfolio currently includes clinical stage investigational drugs to treat neuromuscular or cns symptoms of rare diseases. we will expand our portfolio with other promising therapies that represent important advances in medicine and patient care as well as strong commercial opportunities. a unique opportunity to make a difference approved therapies are available for only about 10% of the 7,000+ known rare diseases. in addition, there are still a number of serious and debilitating diseases that affect larger populations and that do not have adequate treatments available. amo pharma is advancing a new model for drug development with the potential to address health challenges that collectively affect millions of people around the world. most drug development programs, especially in orphan indications, present unique challenges. amo pharma combines a strong commitment to understanding the patient experience with expertise in all aspects of clinical research and global product commercialization to bring a new level of innovation and efficiency to drug development. contact us london uk office kemp house, 152-160 city road, london, ec1v 2nx phone: +44 (0) 1483 319070 email: [email protected] north carolina us office 2608 erwin road, suite 148 box 212, durham, nc 27705 phone: 919-383-1400 fax: 919-383-1433 email: [email protected] patient drug trial information email: [email protected] us toll free: +1 844 583 1231 uk toll free: 44 (0) 800 069 8766 site map home about leadership investors amo pharma at a glance pipeline amo-01 amo-02 amo-04 rnd-001 patients phelan-mcdermid syndrome congenital myotonic dystrophy rett syndrome lysosomal storage disorders partnerships news contact us latest news in the media - june 15, 2018 fda grants orphan drug designation to new treatment for rett syndrome more news © amo pharma all rights reserved. privacy policy --

URL analysis for amo-pharma.com

http://www.amo-pharma.com/privacy_policy.htm
http://www.amo-pharma.com/index.htm
http://www.amo-pharma.com/lysosomal_storage_disorders.htm
http://www.amo-pharma.com/congenital_myotonic_dystrophy.htm
http://www.amo-pharma.com/about.htm
http://www.amo-pharma.com/contact.htm
http://www.amo-pharma.com/leadership.htm
http://www.amo-pharma.com/news.htm
http://www.amo-pharma.com/./
http://www.amo-pharma.com/investors.htm
http://www.amo-pharma.com/amo_04.htm
http://www.amo-pharma.com/rnd_001.htm
http://www.amo-pharma.com/at_a_glance.htm
http://www.amo-pharma.com/rett_syndrome.htm
http://www.amo-pharma.com/partnerships.htm

Whois Information

Whois is a protocol that is access to registering information. You can reach when the website was registered, when it will be expire, what is contact details of the site with the following informations. In a nutshell, it includes these informations;

Domain Name: AMO-PHARMA.COM
Registry Domain ID: 1902107744_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.register.it
Registrar URL: http://www.register.it
Updated Date: 2017-02-13T10:56:07Z
Creation Date: 2015-02-11T10:52:11Z
Registry Expiry Date: 2019-02-11T10:52:11Z
Registrar: Register.it SPA
Registrar IANA ID: 168
Registrar Abuse Contact Email: [email protected]
Registrar Abuse Contact Phone: +39.5520021555
Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Name Server: NS0.PHASE8.NET
Name Server: NS1.PHASE8.NET
Name Server: NS2.PHASE8.NET
DNSSEC: unsigned
URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last update of whois database: 2017-10-14T02:46:20Z <<<

For more information on Whois status codes, please visit https://icann.org/epp

NOTICE: The expiration date displayed in this record is the date the
registrar's sponsorship of the domain name registration in the registry is
currently set to expire. This date does not necessarily reflect the expiration
date of the domain name registrant's agreement with the sponsoring
registrar. Users may consult the sponsoring registrar's Whois database to
view the registrar's reported date of expiration for this registration.

TERMS OF USE: You are not authorized to access or query our Whois
database through the use of electronic processes that are high-volume and
automated except as reasonably necessary to register domain names or
modify existing registrations; the Data in VeriSign Global Registry
Services' ("VeriSign") Whois database is provided by VeriSign for
information purposes only, and to assist persons in obtaining information
about or related to a domain name registration record. VeriSign does not
guarantee its accuracy. By submitting a Whois query, you agree to abide
by the following terms of use: You agree that you may use this Data only
for lawful purposes and that under no circumstances will you use this Data
to: (1) allow, enable, or otherwise support the transmission of mass
unsolicited, commercial advertising or solicitations via e-mail, telephone,
or facsimile; or (2) enable high volume, automated, electronic processes
that apply to VeriSign (or its computer systems). The compilation,
repackaging, dissemination or other use of this Data is expressly
prohibited without the prior written consent of VeriSign. You agree not to
use electronic processes that are automated and high-volume to access or
query the Whois database except as reasonably necessary to register
domain names or modify existing registrations. VeriSign reserves the right
to restrict your access to the Whois database in its sole discretion to ensure
operational stability. VeriSign may restrict or terminate your access to the
Whois database for failure to abide by these terms of use. VeriSign
reserves the right to modify these terms at any time.

The Registry database contains ONLY .COM, .NET, .EDU domains and
Registrars.

  REGISTRAR Register.it SPA

SERVERS

  SERVER com.whois-servers.net

  ARGS domain =amo-pharma.com

  PORT 43

  TYPE domain

DOMAIN

  NAME amo-pharma.com

  CHANGED 2017-02-13

  CREATED 2015-02-11

STATUS
clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
clientTransferProhibited https://icann.org/epp#clientTransferProhibited
clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited

NSERVER

  NS0.PHASE8.NET 81.88.63.114

  NS1.PHASE8.NET 85.233.160.68

  NS2.PHASE8.NET 85.233.164.62

  REGISTERED yes

Mistakes

The following list shows you to spelling mistakes possible of the internet users for the website searched .